Quinapril recalls
Quinapril products have been recalled 5 times, most recently on 28 Dec 2022. The recalling company is usually Lupin Pharmaceuticals. The most common reason is potency & assay.
Total recalls5since 2014
Last 12 months0reported
Class I00% of total
Ongoing0latest 28 Dec 2022
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 4 80%Class III 1 20%
Why quinapril is recalled
Companies
Product types
By year
All quinapril recalls, newest first
5 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Quinapril Tablets USP, 40 mg recalled by Lupin PharmaceuticalsQuinapril | Lupin Pharmaceuticals | Nitrosamine Impurity | Nationwide |
| Drug | CLASS II | Quinapril Tablets USP, 20 mg recalled by Lupin PharmaceuticalsQuinapril | Lupin Pharmaceuticals | Nitrosamine Impurity | Nationwide |
| Drug | CLASS III | Quinapril Tablets USP 5 mg, Lupin Pharmaceuticals, Inc. recalledQuinapril | Lupin Pharmaceuticals | Potency & Assay | Nationwide |
| Drug | CLASS II | Quinapril Tablets USP, 5 mg recalled by Lupin PharmaceuticalsQuinapril | Lupin Pharmaceuticals | Potency & Assay | Nationwide |
| Drug | CLASS II | Quinapril Tablets USP, 10 mg recalled by Lupin PharmaceuticalsQuinapril | Lupin Pharmaceuticals | Potency & Assay | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.